Iqbal J. Hussain - 31 Mar 2024 Form 4 Insider Report for Centessa Pharmaceuticals plc (CNTA)

Role
General Counsel
Signature
/s/ Gregory Weinhoff, attorney-in-fact
Issuer symbol
CNTA
Transactions as of
31 Mar 2024
Net transactions value
-$84,976
Form type
4
Filing time
02 Apr 2024, 16:16:51 UTC
Previous filing
02 Feb 2024
Next filing
02 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNTA Ordinary Shares Tax liability $84,976 -7,520 -3.4% $11.30 212,530 31 Mar 2024 Direct F1, F2
holding CNTA Ordinary Shares 5,500 31 Mar 2024 By spouse F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Represents the number of shares withheld by the Issuer to cover tax withholding obligations in connection with the vesting of restricted share units.